Medicine and Dentistry
Adenovirus Vector
18%
Alternative Complement Pathway C3 C5 Convertase
45%
Analysis
9%
Antigen
27%
Aortic Smooth Muscle Cell
36%
Assay
9%
Binding Affinity
18%
Gel Mobility Shift Assay
9%
Immunohistochemistry
9%
Inducible Nitric Oxide Synthase
9%
Infection
9%
Messenger RNA
36%
Mutant
18%
Nitric Oxide
72%
Nitric Oxide Donor
9%
Northern Blotting
9%
Nuclear Factor
45%
Pyrrolidine Dithiocarbamate
18%
Regulatory Mechanism
9%
Smooth Muscle Cell
9%
Steady State
18%
Study Design
27%
Synthetase
9%
Therapeutic Procedure
18%
Thromboplastin
100%
Upregulation
9%
Vascular Smooth Muscle Cell
9%
INIS
antigens
27%
concentration
9%
design
9%
electrophoresis
9%
gels
9%
humans
18%
inhibition
9%
levels
9%
messenger-rna
36%
mobility
9%
muscles
54%
mutants
18%
nitric oxide
90%
pyrrolidines
18%
rats
36%
regulations
9%
steady-state conditions
18%
time dependence
9%
tissues
100%
vectors
18%
Pharmacology, Toxicology and Pharmaceutical Science
Adenovirus Vector
18%
Alternative Complement Pathway C3 C5 Convertase
45%
Antigen
27%
Inducible Nitric Oxide Synthase
9%
Infection
9%
Messenger RNA
36%
Nitric Oxide
72%
Nitric Oxide Donor
9%
Nuclear Factor
45%
Pyrrolidine Dithiocarbamate
18%
Rat
36%
S-Nitroso-N-Acetylpenicillamine
18%
Synthetase
9%
Thromboplastin
100%
Biochemistry, Genetics and Molecular Biology
Adenovirus Vector
18%
Binding Affinity
18%
Electrophoretic Mobility Shift Assay
9%
Messenger RNA
36%
Mutant
18%
Nitric Oxide
81%
Nitric Oxide Synthase
9%
Nitric Oxide Synthase
9%
Northern Blotting
9%
Pyrrolidine Dithiocarbamate
18%
Rat
36%
Regulatory Mechanism
9%
S-Nitroso-N-Acetylpenicillamine
18%
Steady State
18%
Time
9%
Tissue Factor
100%
Upregulation
9%